新聞Arraybiopharma increases headcount by 100.The 22-acre expansion will allow Array to hire nearly 100 new employees over the next several years.
新聞Arraybiopharma is developing ARRY-380 on May 30th '21.Oncothyreon Inc. (NASDAQ: ONTY ) and Array BioPharma Inc. (NASDAQ: ARRY ) today announced that they will collaborate to develop and commercialize ARRY-380, an orally active, reversible and selective small-molecule HER2 inhibitor.
新聞Thomas left Arraybiopharma as Vice President of Clinical Development of the company’s oncology division on Apr 11th '20.Dr. Thomas joins Caribou from Array Biopharma where she most recently served as Vice President of Clinical Development of the company’s oncology division.
